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Introduction
The NLRs (Nucleotide-binding domain and Leucine-rich
repeat containing Receptors) are a family of intracellular
innate immune receptors involved in host defense. Upon
activation, NLRs form large protein complexes called
“inflammasomes” that bind and activate Caspase-1,
resulting in proteolytic activation of the pro-inflammatory
cytokines pro-IL-1b and pro-IL-18 and also induce a
Caspase-1-dependent form of cell death known as
pyroptosis.
Objectives
Activating mutations in NLRP3 trigger the inflammasome
and cause a spectrum of auto-inflammatory disease.
Therefore our objective was to establish if activating muta-
tions in NLRP1 also cause autoinflammatory disease.
Methods
We performed an N-ethyl-N-nitrosourea (ENU) mutagen-
esis screen for dominant mutations that cause neutrophilia
in G1 mice and isolated a pedigree with a mutation in
NLRP1a.
Results
Mice with the mutation Nlrp1a+/Q593P were fertile and
remained healthy to at least 8 months of age, despite
histological evidence of a multi-organ neutrophilic
inflammatory disease characterised by meningitis, hepa-
titis, pneumonitis, pancreatitis, pulmonary peri-arteritis,
myocarditis and inflammatory bowel disease. In
Nlrp1aQ593P/Q593P homozygotes, a similar but lethal con-
dition developed by 3-5 months of age. Neutrophil
counts in these animals were 15-fold higher than wild-
type, and they exhibited lymphopenia and splenomegaly.
By breeding with genetically deficient mice we showed
that the lethal systemic inflammatory disease was amelio-
rated by removing Caspase-1 and IL-1R but was indepen-
dent of ASC. On the other hand, deletion of IL-18
increased the number of neutrophils in the blood, and
greatly accelerated the onset of disease.
Conclusion
In summary we show for the first time in vivo the effect of
an activating mutation in NLRP1, which causes autoin-
flammatory disease. We demonstrate that this disease is
caused by IL-1b and Caspase-1, but not ASC. Surprisingly,
IL-18 is beneficial for this condition, suggesting that
caution should be employed when blocking IL-18 in
human autoinflammatory diseases. Our results strongly
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